|
1
|
Slawson C, Copeland RJ and Hart GW:
O-GlcNAc signaling: A metabolic link between diabetes and cancer?
Trends Biochem Sci. 35:547–555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haltiwanger RS, Holt GD and Hart GW:
Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins.
Identification of a uridine diphospho-N-acetylglucosamine:peptide
beta-N-acetylglucosaminyltransferase. J Biol Chem. 265:2563–2568.
1990.PubMed/NCBI
|
|
3
|
Dong DL and Hart GW: Purification and
characterization of an O-GlcNAc selective
N-acetyl-β-D-glucosaminidase from rat spleen cytosol. J Biol Chem.
269:19321–19330. 1994.PubMed/NCBI
|
|
4
|
Caldwell SA, Jackson SR, Shahriari KS,
Lynch TP, Sethi G, Walker S, Vosseller K and Reginato MJ: Nutrient
sensor O-GlcNAc transferase regulates breast cancer tumorigenesis
through targeting of the oncogenic transcription factor FoxM1.
Oncogene. 29:2831–2842. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C,
Yang J, Han F, Lu X and Yu W: GlcNAcylation plays an essential role
in breast cancer metastasis. Cancer Res. 70:6344–6351. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mi W, Gu Y, Han C, Liu H, Fan Q, Zhang X,
Cong Q and Yu W: O-GlcNAcylation is a novel regulator of lung and
colon cancer malignancy. Biochim Biophys Acta. 1812:514–519. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Starska K, Forma E, Brzezińska-Błaszczyk
E, Lewy-Trenda I, Bryś M, Jóźwiak P and Krześlak A: Gene and
protein expression of O-GlcNAc-cycling enzymes in human laryngeal
cancer. Clin Exp Med. Oct 15–2014.PubMed/NCBI
|
|
8
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cunningham D, Jost LM, Purkalne G,
Oliveira J and Force EGT: ESMO Minimum Clinical Recommendations for
diagnosis, treatment and follow-up of gastric cancer. Ann Oncol.
16(Suppl 1): i22–i23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Wen T, Zhu M, Li L, Wei J, Wu X, Guo
M, Liu S, Zhao H, Xia S, et al: Glycoproteomic analysis of tissues
from patients with colon cancer using lectin microarrays and
nanoLC-MS/MS. Mol Biosyst. 9:1877–1887. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krześlak A, Forma E, Bernaciak M,
Romanowicz H and Bryś M: Gene expression of O-GlcNAc cycling
enzymes in human breast cancers. Clin Exp Med. 12:61–65. 2012.
View Article : Google Scholar
|
|
13
|
Kamigaito T, Okaneya T, Kawakubo M,
Shimojo H, Nishizawa O and Nakayama J: Overexpression of O-GlcNAc
by prostate cancer cells is significantly associated with poor
prognosis of patients. Prostate Cancer Prostatic Dis. 17:18–22.
2014. View Article : Google Scholar
|
|
14
|
Zhu Q, Zhou L, Yang Z, Lai M, Xie H, Wu L,
Xing C, Zhang F and Zheng S: O-GlcNAcylation plays a role in tumor
recurrence of hepatocellular carcinoma following liver
transplantation. Med Oncol. 29:985–993. 2012. View Article : Google Scholar
|
|
15
|
Shi Y, Tomic J, Wen F, Shaha S, Bahlo A,
Harrison R, Dennis JW, Williams R, Gross BJ, Walker S, et al:
Aberrant O-GlcNAcylation characterizes chronic lymphocytic
leukemia. Leukemia. 24:1588–1598. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Donnell N, Zachara NE, Hart GW and Marth
JD: Ogt-dependent X-chromosome-linked protein glycosylation is a
requisite modification in somatic cell function and embryo
viability. Mol Cell Biol. 24:1680–1690. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shafi R, Iyer SP, Ellies LG, O'Donnell N,
Marek KW, Chui D, Hart GW and Marth JD: The O-GlcNAc transferase
gene resides on the X chromosome and is essential for embryonic
stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA.
97:5735–5739. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marshall S: Role of insulin, adipocyte
hormones, and nutrient-sensing pathways in regulating fuel
metabolism and energy homeostasis: A nutritional perspective of
diabetes, obesity, and cancer. Sci STKE. 2006:re72006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ferrer CM, Lynch TP, Sodi VL, Falcone JN,
Schwab LP, Peacock DL, Vocadlo DJ, Seagroves TN and Reginato MJ:
O-GlcNAcylation regulates cancer metabolism and survival stress
signaling via regulation of the HIF-1 pathway. Mol Cell.
54:820–831. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ding WX, Ni HM, Chen X, Yu J, Zhang L and
Yin XM: A coordinated action of Bax, PUMA, and p53 promotes
MG132-induced mitochondria activation and apoptosis in colon cancer
cells. Mol Cancer Ther. 6:1062–1069. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakano K and Vousden KH: PUMA, a novel
proapoptotic gene, is induced by p53. Mol Cell. 7:683–694. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yotsumoto F, Yagi H, Suzuki SO, Oki E,
Tsujioka H, Hachisuga T, Sonoda K, Kawarabayashi T, Mekada E and
Miyamoto S: Validation of HB-EGF and amphiregulin as targets for
human cancer therapy. Biochem Biophys Res Commun. 365:555–561.
2008. View Article : Google Scholar
|
|
23
|
Sturm A, Lensch M, André S, Kaltner H,
Wiedenmann B, Rosewicz S, Dignass AU and Gabius HJ: Human
galectin-2: Novel inducer of T cell apoptosis with distinct profile
of caspase activation. J Immunol. 173:3825–3837. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paclik D, Danese S, Berndt U, Wiedenmann
B, Dignass A and Sturm A: Galectin-4 controls intestinal
inflammation by selective regulation of peripheral and mucosal T
cell apoptosis and cell cycle. PLoS One. 3:e26292008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuwabara I, Kuwabara Y, Yang RY, Schuler
M, Green DR, Zuraw BL, Hsu DK and Liu FT: Galectin-7 (PIG1)
exhibits pro-apoptotic function through JNK activation and
mitochondrial cytochrome c release. J Biol Chem. 277:3487–3497.
2002. View Article : Google Scholar
|
